Article
Regeneron, Alnylam to Advance NASH Candidate Into Phase 2 >REGN ALNY
Rating:
0.0
Views:
89
Likes:
1
Library:
1
By Colin Kellaher Regeneron Pharmaceuticals Inc. and Alnylam Pharmaceuticals Inc. on Thursday said preliminary Phase 1 data supports the clinical advancement...
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value